News
-
-
PRESS RELEASE
Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds
Gerresheimer reports solid financial results in 2024 with revenue up 2.9% and adjusted EBITDA up 4.1%. Strategies for growth include expansions and focus on biologics solutions. Bormioli Pharma integration to boost revenues from 2025 -
-
-
-
-
-
PRESS RELEASE
BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growth in the core BRAINBiocatalysts division
BRAIN Biotech AG reports 11% organic growth in Q1 of FY 24/25 for BRAINBiocatalysts, forecasts strong growth and solid EBITDA margin, maintains strong cash position of €17.8 million -
PRESS RELEASE
Evotec announces change in Management Board
Evotec SE announces change in Management Board with Laetitia Rouxel stepping down as CFO and Paul Hitchin appointed as her successor. Rouxel to leave the Company on 31st March 2025. Hitchin brings over 20 years of finance leadership experience -